Vyant Bio Inc. sell Global_Player
Start price
30.03.22
/
50%
€8.50
Target price
30.03.23
-
Performance (%)
-24.12%
End price
31.03.22
€6.45
Summary
This prediction ended on 31.03.22 with a price of €6.45. The price of Vyant Bio Inc. decreased from the start of the prediction. Compared to the start price this resulted in a performance of -24.12%. Global_Player has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vyant Bio Inc. | - | - | - | - |
| iShares Core DAX® | -1,86 % | 0,67 % | 0,92 % | 51,85 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % | 33,72 % | 86,85 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % | 52,96 % | 63,32 % |
| iShares S&P 500 | -1,31 % | 3,40 % | 24,67 % | 66,11 % |
According to Global_Player what are the pros and cons of Vyant Bio Inc. for the foreseeable future?
Pros
Cons
Risky Investment
Comments by Global_Player for this prediction
In the thread Cancer Genetics Inc. diskutieren
Sell Vyant Bio Inc.